The post Gaurab Chakrabarti: Solugen’s fusion of biology and chemistry boosts chemical yields, leveraging pancreatic cancer mechanisms for hydrogen peroxide, andThe post Gaurab Chakrabarti: Solugen’s fusion of biology and chemistry boosts chemical yields, leveraging pancreatic cancer mechanisms for hydrogen peroxide, and

Gaurab Chakrabarti: Solugen’s fusion of biology and chemistry boosts chemical yields, leveraging pancreatic cancer mechanisms for hydrogen peroxide, and the importance of deep customer understanding

2026/03/24 08:05
Okuma süresi: 11 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen crypto.news@mexc.com üzerinden bizimle iletişime geçin.


Solugen’s innovative enzyme-based process revolutionizes chemical manufacturing, offering sustainable alternatives to traditional methods.

Key takeaways

  • Solugen’s process combines biology with chemistry to significantly improve chemical manufacturing efficiency.
  • The company is pioneering the fusion of biological enzymes with metal catalysts to achieve higher yields.
  • Leveraging the mechanisms of pancreatic cancer cells, Solugen developed a novel method for producing industrial hydrogen peroxide.
  • Organic enzymes can operate efficiently at an industrial scale, challenging traditional chemical production beliefs.
  • Cygene’s strategy of building a low-cost reactor enabled rapid market entry and scaling.
  • Initial manual production processes at Solugen highlighted the resourcefulness required in early-stage startups.
  • Deep customer understanding is crucial for developing successful products and achieving product-market fit.
  • A startup’s core idea can remain unchanged even as its execution and scale evolve.
  • The efficiency of enzymes used in Solugen’s production process results in high output from minimal input.
  • Creating a culture that embraces failure is essential for fostering innovation and problem-solving.
  • Solugen’s unique approach provides a competitive advantage in the chemical manufacturing industry.
  • The integration of biology and chemistry in production processes promotes environmentally friendly practices.

Guest intro

Gaurab Chakrabarti is the co-founder and CEO of Solugen, a company reinventing the chemical manufacturing industry through enzymatic and catalytic production processes. He founded Solugen in 2016 after applying enzymes from his pancreatic cancer research to create sustainable alternatives like hydrogen peroxide from sugar feedstocks instead of oil and gas. A physician-scientist with an MD and PhD from the University of Texas, he has grown Solugen from a $7,000 PVC reactor into a billion-dollar enterprise.

Solugen’s innovative approach to chemical manufacturing

  • Solugen combines biology and chemistry to enhance manufacturing efficiency.
  • — Gaurab Chakrabarti

  • The fusion of enzymes from living cells with metal catalysts is a unique approach in the industry.
  • — Gaurab Chakrabarti

  • Solugen’s process significantly improves yield, showcasing technological advancement.
  • The company’s innovative methods promote environmentally friendly practices.
  • Solugen’s approach provides a competitive advantage in chemical manufacturing.
  • Understanding the significance of combining biological enzymes with metal catalysts is crucial for appreciating Solugen’s process.

Leveraging biological mechanisms for industrial processes

  • Solugen uses pancreatic cancer cell mechanisms to create industrial hydrogen peroxide.
  • — Gaurab Chakrabarti

  • This novel application showcases innovation in chemical production.
  • Organic enzymes can operate at industrial scale and efficiency.
  • — Gaurab Chakrabarti

  • The potential for biological processes to be economically viable challenges traditional beliefs.
  • Understanding biochemical processes in pancreatic cancer is key to this innovation.
  • Solugen’s approach demonstrates the potential of integrating biology with industrial chemistry.

Strategic innovation in startup funding and scaling

  • Cygene built its first reactor for just $10,000, allowing rapid market entry.
  • — Gaurab Chakrabarti

  • This strategy highlights operational efficiency and resourcefulness.
  • Initial product was made manually due to budget constraints.
  • — Gaurab Chakrabarti

  • Manual production processes illustrate the challenges faced by early-stage startups.
  • Understanding typical funding and scaling strategies in biotech startups is essential.
  • Cygene’s approach informs other entrepreneurs about strategic innovation.

Importance of customer understanding in product development

  • Deep customer knowledge is crucial for building successful products.
  • — Gaurab Chakrabarti

  • Understanding customers helps achieve product-market fit.
  • Y Combinator’s approach emphasizes customer development.
  • Customer insights guide the development of products that meet market needs.
  • Entrepreneurs benefit from understanding their customers deeply.
  • Customer knowledge is a key principle in entrepreneurship.
  • Building a successful product requires expertise in the customer’s world.

Stability of core ideas in evolving startups

  • A startup’s core idea can remain unchanged despite changes in execution and scale.
  • — Gaurab Chakrabarti

  • Foundational ideas provide stability as startups grow.
  • Understanding the evolution of startups is crucial for entrepreneurs.
  • Changes in scale and execution do not necessarily alter the core concept.
  • Entrepreneurs should focus on the stability of their foundational ideas.
  • The core idea’s stability is valuable for long-term success.
  • Startups can evolve while maintaining their original vision.

Efficiency in enzyme-based production processes

  • The enzyme used in production is highly efficient, allowing for significant output.
  • — Gaurab Chakrabarti

  • High enzyme efficiency demonstrates the effectiveness of Solugen’s technology.
  • Minimal input results in substantial production output.
  • Understanding the role of enzymes in chemical manufacturing is essential.
  • Solugen’s production process showcases technological advancement.
  • The efficiency of enzymes is a critical aspect of the production process.
  • Solugen’s approach highlights the potential of enzyme-based manufacturing.

Embracing failure to foster innovation

  • Creating a culture that embraces failure is crucial for innovation.
  • — Gaurab Chakrabarti

  • A failure-tolerant culture fosters problem-solving and innovation.
  • Companies in rapidly evolving industries benefit from embracing failure.
  • Innovation requires a mindset that accepts and learns from mistakes.
  • Cultural mindset is vital for addressing future challenges.
  • Embracing failure is essential for companies in emerging technologies.
  • Innovation thrives in a culture that encourages experimentation and learning.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Solugen’s innovative enzyme-based process revolutionizes chemical manufacturing, offering sustainable alternatives to traditional methods.

Key takeaways

  • Solugen’s process combines biology with chemistry to significantly improve chemical manufacturing efficiency.
  • The company is pioneering the fusion of biological enzymes with metal catalysts to achieve higher yields.
  • Leveraging the mechanisms of pancreatic cancer cells, Solugen developed a novel method for producing industrial hydrogen peroxide.
  • Organic enzymes can operate efficiently at an industrial scale, challenging traditional chemical production beliefs.
  • Cygene’s strategy of building a low-cost reactor enabled rapid market entry and scaling.
  • Initial manual production processes at Solugen highlighted the resourcefulness required in early-stage startups.
  • Deep customer understanding is crucial for developing successful products and achieving product-market fit.
  • A startup’s core idea can remain unchanged even as its execution and scale evolve.
  • The efficiency of enzymes used in Solugen’s production process results in high output from minimal input.
  • Creating a culture that embraces failure is essential for fostering innovation and problem-solving.
  • Solugen’s unique approach provides a competitive advantage in the chemical manufacturing industry.
  • The integration of biology and chemistry in production processes promotes environmentally friendly practices.

Guest intro

Gaurab Chakrabarti is the co-founder and CEO of Solugen, a company reinventing the chemical manufacturing industry through enzymatic and catalytic production processes. He founded Solugen in 2016 after applying enzymes from his pancreatic cancer research to create sustainable alternatives like hydrogen peroxide from sugar feedstocks instead of oil and gas. A physician-scientist with an MD and PhD from the University of Texas, he has grown Solugen from a $7,000 PVC reactor into a billion-dollar enterprise.

Solugen’s innovative approach to chemical manufacturing

  • Solugen combines biology and chemistry to enhance manufacturing efficiency.
  • — Gaurab Chakrabarti

  • The fusion of enzymes from living cells with metal catalysts is a unique approach in the industry.
  • — Gaurab Chakrabarti

  • Solugen’s process significantly improves yield, showcasing technological advancement.
  • The company’s innovative methods promote environmentally friendly practices.
  • Solugen’s approach provides a competitive advantage in chemical manufacturing.
  • Understanding the significance of combining biological enzymes with metal catalysts is crucial for appreciating Solugen’s process.

Leveraging biological mechanisms for industrial processes

  • Solugen uses pancreatic cancer cell mechanisms to create industrial hydrogen peroxide.
  • — Gaurab Chakrabarti

  • This novel application showcases innovation in chemical production.
  • Organic enzymes can operate at industrial scale and efficiency.
  • — Gaurab Chakrabarti

  • The potential for biological processes to be economically viable challenges traditional beliefs.
  • Understanding biochemical processes in pancreatic cancer is key to this innovation.
  • Solugen’s approach demonstrates the potential of integrating biology with industrial chemistry.

Strategic innovation in startup funding and scaling

  • Cygene built its first reactor for just $10,000, allowing rapid market entry.
  • — Gaurab Chakrabarti

  • This strategy highlights operational efficiency and resourcefulness.
  • Initial product was made manually due to budget constraints.
  • — Gaurab Chakrabarti

  • Manual production processes illustrate the challenges faced by early-stage startups.
  • Understanding typical funding and scaling strategies in biotech startups is essential.
  • Cygene’s approach informs other entrepreneurs about strategic innovation.

Importance of customer understanding in product development

  • Deep customer knowledge is crucial for building successful products.
  • — Gaurab Chakrabarti

  • Understanding customers helps achieve product-market fit.
  • Y Combinator’s approach emphasizes customer development.
  • Customer insights guide the development of products that meet market needs.
  • Entrepreneurs benefit from understanding their customers deeply.
  • Customer knowledge is a key principle in entrepreneurship.
  • Building a successful product requires expertise in the customer’s world.

Stability of core ideas in evolving startups

  • A startup’s core idea can remain unchanged despite changes in execution and scale.
  • — Gaurab Chakrabarti

  • Foundational ideas provide stability as startups grow.
  • Understanding the evolution of startups is crucial for entrepreneurs.
  • Changes in scale and execution do not necessarily alter the core concept.
  • Entrepreneurs should focus on the stability of their foundational ideas.
  • The core idea’s stability is valuable for long-term success.
  • Startups can evolve while maintaining their original vision.

Efficiency in enzyme-based production processes

  • The enzyme used in production is highly efficient, allowing for significant output.
  • — Gaurab Chakrabarti

  • High enzyme efficiency demonstrates the effectiveness of Solugen’s technology.
  • Minimal input results in substantial production output.
  • Understanding the role of enzymes in chemical manufacturing is essential.
  • Solugen’s production process showcases technological advancement.
  • The efficiency of enzymes is a critical aspect of the production process.
  • Solugen’s approach highlights the potential of enzyme-based manufacturing.

Embracing failure to foster innovation

  • Creating a culture that embraces failure is crucial for innovation.
  • — Gaurab Chakrabarti

  • A failure-tolerant culture fosters problem-solving and innovation.
  • Companies in rapidly evolving industries benefit from embracing failure.
  • Innovation requires a mindset that accepts and learns from mistakes.
  • Cultural mindset is vital for addressing future challenges.
  • Embracing failure is essential for companies in emerging technologies.
  • Innovation thrives in a culture that encourages experimentation and learning.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Loading more articles…

You’ve reached the end


Add us on Google

`;
}

function createMobileArticle(article) {
const displayDate = getDisplayDate(article);
const editorSlug = article.editor ? article.editor.toLowerCase().replace(/\s+/g, ‘-‘) : ”;
const captionHtml = article.imageCaption ? `

${article.imageCaption}

` : ”;
const authorHtml = article.isPressRelease ? ” : `
`;

return `


${captionHtml}

${article.subheadline ? `

${article.subheadline}

` : ”}

${createSocialShare()}

${authorHtml}
${displayDate}

${article.content}

${article.isPressRelease ? ” : article.isSponsored ? `

Disclosure: This is sponsored content. It does not represent Crypto Briefing’s editorial views. For more information, see our Editorial Policy.

` : `

Disclosure: This article was edited by ${article.editor}. For more information on how we create and review content, see our Editorial Policy.

`}

`;
}

function createDesktopArticle(article, sidebarAdHtml) {
const editorSlug = article.editor ? article.editor.toLowerCase().replace(/\s+/g, ‘-‘) : ”;
const displayDate = getDisplayDate(article);
const captionHtml = article.imageCaption ? `

${article.imageCaption}

` : ”;
const categoriesHtml = article.categories.map((cat, i) => {
const separator = i < article.categories.length – 1 ? ‘|‘ : ”;
return `${cat}${separator}`;
}).join(”);
const desktopAuthorHtml = article.isPressRelease ? ” : `
`;

return `

${categoriesHtml}

${article.subheadline ? `

${article.subheadline}

` : ”}

${desktopAuthorHtml}
${displayDate}
${createSocialShare()}

${captionHtml}

${article.content}
${article.isPressRelease ? ” : article.isSponsored ? `
Disclosure: This is sponsored content. It does not represent Crypto Briefing’s editorial views. For more information, see our Editorial Policy.

` : `

Disclosure: This article was edited by ${article.editor}. For more information on how we create and review content, see our Editorial Policy.

`}

`;
}

function loadMoreArticles() {
if (isLoading || !hasMore) return;

isLoading = true;
loadingText.classList.remove(‘hidden’);

// Build form data for AJAX request
const formData = new FormData();
formData.append(‘action’, ‘cb_lovable_load_more’);
formData.append(‘current_post_id’, lastLoadedPostId);
formData.append(‘primary_cat_id’, primaryCatId);
formData.append(‘before_date’, lastLoadedDate);
formData.append(‘loaded_ids’, loadedPostIds.join(‘,’));

fetch(ajaxUrl, {
method: ‘POST’,
body: formData
})
.then(response => response.json())
.then(data => {
isLoading = false;
loadingText.classList.add(‘hidden’);

if (data.success && data.has_more && data.article) {
const article = data.article;
const sidebarAdHtml = data.sidebar_ad_html || ”;

// Check for duplicates
if (loadedPostIds.includes(article.id)) {
console.log(‘Duplicate article detected, skipping:’, article.id);
// Update pagination vars and try again
lastLoadedDate = article.publishDate;
loadMoreArticles();
return;
}

// Add to mobile container
mobileContainer.insertAdjacentHTML(‘beforeend’, createMobileArticle(article));

// Add to desktop container with fresh ad HTML
desktopContainer.insertAdjacentHTML(‘beforeend’, createDesktopArticle(article, sidebarAdHtml));

// Update tracking variables
loadedPostIds.push(article.id);
lastLoadedPostId = article.id;
lastLoadedDate = article.publishDate;

// Execute any inline scripts in the new content (for ads)
const newArticle = desktopContainer.querySelector(`article[data-article-id=”${article.id}”]`);
if (newArticle) {
const scripts = newArticle.querySelectorAll(‘script’);
scripts.forEach(script => {
const newScript = document.createElement(‘script’);
if (script.src) {
newScript.src = script.src;
} else {
newScript.textContent = script.textContent;
}
document.body.appendChild(newScript);
});
}

// Trigger Ad Inserter if available
if (typeof ai_check_and_insert_block === ‘function’) {
ai_check_and_insert_block();
}

// Trigger Google Publisher Tag refresh if available
if (typeof googletag !== ‘undefined’ && googletag.pubads) {
googletag.cmd.push(function() {
googletag.pubads().refresh();
});
}

} else if (data.success && !data.has_more) {
hasMore = false;
endText.classList.remove(‘hidden’);
} else if (!data.success) {
console.error(‘AJAX error:’, data.error);
hasMore = false;
endText.textContent=”Error loading more articles”;
endText.classList.remove(‘hidden’);
}
})
.catch(error => {
console.error(‘Fetch error:’, error);
isLoading = false;
loadingText.classList.add(‘hidden’);
hasMore = false;
endText.textContent=”Error loading more articles”;
endText.classList.remove(‘hidden’);
});
}

// Set up IntersectionObserver
const observer = new IntersectionObserver(function(entries) {
if (entries[0].isIntersecting) {
loadMoreArticles();
}
}, { threshold: 0.1 });

observer.observe(loadingTrigger);
})();

© Decentral Media and Crypto Briefing® 2026.

Source: https://cryptobriefing.com/gaurab-chakrabarti-solugens-fusion-of-biology-and-chemistry-boosts-chemical-yields-leveraging-pancreatic-cancer-mechanisms-for-hydrogen-peroxide-and-the-importance-of-deep-customer-understanding/

Piyasa Fırsatı
DeepBook Logosu
DeepBook Fiyatı(DEEP)
$0.028919
$0.028919$0.028919
+1.56%
USD
DeepBook (DEEP) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen crypto.news@mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

BitGo expands its presence in Europe

BitGo expands its presence in Europe

The post BitGo expands its presence in Europe appeared on BitcoinEthereumNews.com. BitGo, global leader in digital asset infrastructure, announces a significant expansion of its presence in Europe. The company, through its subsidiary BitGo Europe GmbH, has obtained an extension of the license from BaFin (German Federal Financial Supervisory Authority), allowing it to offer regulated cryptocurrency trading services directly from Frankfurt, Germany. This move marks a decisive step for the European digital asset market, offering institutional investors the opportunity to access secure, regulated cryptocurrency trading integrated with advanced custody and management services. A comprehensive offering for European institutional investors With the extension of the license according to the MiCA (Markets in Crypto-Assets) regulation, initially obtained in May 2025, BitGo Europe expands the range of services available for European investors. Now, in addition to custody, staking, and transfer of digital assets, the platform also offers a spot trading service on thousands of cryptocurrencies and stablecoins. Institutional investors can now leverage BitGo’s OTC desk and a high-performance electronic trading platform, designed to ensure fast, secure, and transparent transactions. Aggregated access to numerous liquidity sources, including leading market makers and exchanges, allows for trading at competitive prices and high-quality executions. Security and Regulation at the Core of BitGo’s Strategy According to Brett Reeves, Head of European Sales and Go Network at BitGo, the goal is clear: “We are excited to strengthen our European platform and enable our clients to operate smoothly, competitively, and securely.§By combining our institutional custody solution with high-performance trading execution, clients will be able to access deep liquidity with the peace of mind that their assets will remain in cold storage, under regulated custody and compliant with MiCA.” The security of digital assets is indeed one of the cornerstones of BitGo’s offering. All services are designed to ensure that investors’ assets remain protected in regulated cold storage, minimizing operational and counterparty risks.…
Paylaş
BitcoinEthereumNews2025/09/18 04:28
Wormhole launches reserve tying protocol revenue to token

Wormhole launches reserve tying protocol revenue to token

The post Wormhole launches reserve tying protocol revenue to token appeared on BitcoinEthereumNews.com. Wormhole is changing how its W token works by creating a new reserve designed to hold value for the long term. Announced on Wednesday, the Wormhole Reserve will collect onchain and offchain revenues and other value generated across the protocol and its applications (including Portal) and accumulate them into W, locking the tokens within the reserve. The reserve is part of a broader update called W 2.0. Other changes include a 4% targeted base yield for tokenholders who stake and take part in governance. While staking rewards will vary, Wormhole said active users of ecosystem apps can earn boosted yields through features like Portal Earn. The team stressed that no new tokens are being minted; rewards come from existing supply and protocol revenues, keeping the cap fixed at 10 billion. Wormhole is also overhauling its token release schedule. Instead of releasing large amounts of W at once under the old “cliff” model, the network will shift to steady, bi-weekly unlocks starting October 3, 2025. The aim is to avoid sharp periods of selling pressure and create a more predictable environment for investors. Lockups for some groups, including validators and investors, will extend an additional six months, until October 2028. Core contributor tokens remain under longer contractual time locks. Wormhole launched in 2020 as a cross-chain bridge and now connects more than 40 blockchains. The W token powers governance and staking, with a capped supply of 10 billion. By redirecting fees and revenues into the new reserve, Wormhole is betting that its token can maintain value as demand for moving assets and data between chains grows. This is a developing story. This article was generated with the assistance of AI and reviewed by editor Jeffrey Albus before publication. Get the news in your inbox. Explore Blockworks newsletters: Source: https://blockworks.co/news/wormhole-launches-reserve
Paylaş
BitcoinEthereumNews2025/09/18 01:55
SlowMist: Attackers have stolen approximately 300GB of data due to the LiteLLM vulnerability. Encryption developers are advised to conduct an immediate self-check.

SlowMist: Attackers have stolen approximately 300GB of data due to the LiteLLM vulnerability. Encryption developers are advised to conduct an immediate self-check.

PANews reported on March 25th that 23pds, Chief Information Security Officer of SlowMist Technology, issued another warning regarding the LiteLLM attack: "All cryptocurrency
Paylaş
PANews2026/03/25 10:30